NCT00537719View on ClinicalTrials.gov

Scintigraphy Study to Assess Gastric Emptying in Healthy Subjects Given GSK716155 or Placebo.

PHASE1CompletedINTERVENTIONAL

Enrollment

34

Participants

Timeline

Start Date

December 7, 2007

Primary Completion Date

April 4, 2008

Study Completion Date

April 4, 2008

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG

GSK716155

albiglutide subcutaneous injection

DRUG

Placebo

placebo injection

Trial Locations (1)

40503

GSK Investigational Site, Lexington

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY

NCT00537719 - Scintigraphy Study to Assess Gastric Emptying in Healthy Subjects Given GSK716155 or Placebo. | Biotech Hunter | Biotech Hunter